Duloxetine to Prevent Oxaliplatin-Induced Chemotherapy-Induced Peripheral Neuropathy: A Randomized, Double-Blind, Placebo-Controlled Phase II to Phase III Study

Grant

Awarded By

Total Award Amount

  • 1055322.00

    • Direct Costs

  • 730582.00

    • Sponsor Award Id

  • R01CA235726

    • Contributor

  • Ellen Smith   Principal Investigator